We were on the cusp of an EUA in June/July of 2020
Post# of 148173
(Total Views: 526)
Posted On: 12/15/2021 3:02:53 PM
We were on the cusp of an EUA in June/July of 2020 and we've been suppressed ever since. The company that benefited the most was Gilead Sciences with remdesivir, ( May 2020 - CytoDyn to Prepare a Phase 3 Protocol to Submit to the FDA for a Three-Arm Comparative and Combination Trial of Leronlimab and Remdesivir), and the other company was Regeneron with REGN-Cov2.
I always felt weird about Gilead because first we were going to do a trial with them, then that is dropped, and Remdesivir is given an EUA and then later we discover our CD12 is being 'helped" by people with connections to Gilead.
I always felt weird about Gilead because first we were going to do a trial with them, then that is dropped, and Remdesivir is given an EUA and then later we discover our CD12 is being 'helped" by people with connections to Gilead.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼